EDP Sciences logo
Submit your paper
Search
Menu
Home All issues Volume 31 / No 2 (2025) J Oral Med Oral Surg, 31 2 (2025) 10 References
Open Access
Issue
J Oral Med Oral Surg
Volume 31, Number 2, 2025
Article Number 10
Number of page(s) 9
DOI https://doi.org/10.1051/mbcb/2025014
Published online 29 April 2025
  1. Piñas L, García-García A, Pérez-Sayáns M, Suárez-Fernández R, Alkhraisat MH, Anitua E. The use of topical corticosteroids in the treatment of oral lichen planus in Spain: a national survey. Med Oral Patol Oral Cir Bucal 2017; 22: e264–e269. [PubMed] [Google Scholar]
  2. Ioannides D, Vakirlis E, Kemeny L, Marinovic B, Massone C, Murphy R, et al. European S1 guidelines on the management of lichen planus: a cooperation of the European Dermatology Forum with the European Academy of Dermatology and Venereology. J Eur Acad Dermatol Venereol 2020; 34: 1403–1414. [Google Scholar]
  3. Huang MY, Armstrong AW. Janus-kinase inhibitors in dermatology: a review of their use in psoriasis, vitiligo, systemic lupus erythematosus, hidradenitis suppurativa, dermatomyositis, lichen planus, lichen planopilaris, sarcoidosis and graft-versus-host disease. Indian J Dermatol Venereol Leprol 2023; 90: 30–40. [Google Scholar]
  4. Al-Hashimi I, Schifter M, Lockhart PB, Wray D, Brennan M, Migliorati CA, et al. Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103 Suppl: S25.e1–12. [PubMed] [Google Scholar]
  5. Escudier M, Ahmed N, Shirlaw P, Setterfield J, Tappuni A, Black MM, et al. A scoring system for mucosal disease severity with special reference to oral lichen planus. Br J Dermatol 2007; 157: 765–77. [Google Scholar]
  6. Rotaru D, Chisnoiu R, Picos AM, Picos A, Chisnoiu A. Treatment trends in oral lichen planus and oral lichenoid lesions. Exp Ther Med 2020; 20: 198. [PubMed] [Google Scholar]
  7. Kassem R, Yarom N, Scope A, Babaev M, Trau H, Pavlotzky F. Treatment of erosive oral lichen planus with local ultraviolet B phototherapy. J Am Acad Dermatol 2012; 66: 761–766. [Google Scholar]
  8. G Gorouhi F, Davari P, Fazel N. Cutaneous and mucosal lichen planus: a comprehensive review of clinical subtypes, risk factors, diagnosis and prognosis. ScientificWorldJournal 2014; 2014: 742826. [PubMed] [Google Scholar]
  9. Seintou A, Gaydarov N, Lombardi T, Samson J. Histoire naturelle et transformation maligne du lichen plan buccal. 1ère partie: mise au point. Med Buccale Chir Buccale 2012; 18: 89–107. [CrossRef] [EDP Sciences] [Google Scholar]
  10. Odi G, Manfredi M, Mercadante V, Murphy R, Carrozzo M. Interventions for treating oral lichen planus: corticosteroid therapies. Cochrane Database Syst Rev 2020; 2: CD001168. [PubMed] [Google Scholar]
  11. Łukaszewska-Kuska M, Ślebioda Z, Dorocka-Bobkowska B. The effectiveness of topical forms of dexamethasone in the treatment of oral lichen planus: a systematic review. Oral Dis 2022; 28: 2063–2071. [CrossRef] [PubMed] [Google Scholar]
  12. Davari P, Hsiao HH, Fazel N. Mucosal lichen planus: an evidence-based treatment update. Am J Clin Dermatol 2014; 15: 181–195. [CrossRef] [PubMed] [Google Scholar]
  13. Cunningham CT, Quan H, Hemmelgarn B, Noseworthy T, Beck CA, Dixon E, et al. Exploring physician specialist response rates to web-based surveys. BMC Med Res Methodol 2015; 15: 32. [Google Scholar]
  14. Carbone M, Goss E, Carrozzo M, Castellano S, Conrotto D, Broccoletti R, et al. Systemic and topical corticosteroid treatment of oral lichen planus: a comparative study with long-term follow-up. J Oral Pathol Med 2003; 32: 323–329. [Google Scholar]
  15. Vincent SD. Diagnosing and managing oral lichen planus. J Am Dent Assoc 1991; 122: 93–94, 96. [Google Scholar]
  16. Wang J, van der Waal I. Disease scoring systems for oral lichen planus: a critical appraisal. Med Oral Patol Oral Cir Bucal 2015; 20: e199–e204. [CrossRef] [PubMed] [Google Scholar]
  17. E Elsabagh HH, Gaweesh YY, Ghonima JK, Gebril M. A novel comprehensive scoring system for oral lichen planus: a validity, diagnostic accuracy and clinical sensitivity study. Oral Surg Oral Med Oral Pathol Oral Radiol 2021; 131: 304–311. [CrossRef] [PubMed] [Google Scholar]
  18. Gonzalez-Moles MA, Ruiz-Avila I, Rodriguez-Archilla A, Morales-Garcia P, Mesa-Aguado F, Bascones-Martinez A, et al. Treatment of severe erosive gingival lesions by topical application of clobetasol propionate in custom trays. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 95: 688–692. [Google Scholar]
  19. Tillero R, González-Serrano J, Caponio VCA, Serrano J, Hernández G, López-Pintor RM. Efficacy of antimalarials in oral lichen planus: a systematic review. Oral Dis 2024; 30: 4098–4112. [CrossRef] [PubMed] [Google Scholar]
  20. Gamal Alsakaan NA, Abd-Elsalam S, Fawzy MM, Elwan NM. Efficacy and safety of oral methotrexate versus oral mini pulse betamethasone therapy in the treatment of lichen planus: a comparative study. J Dermatolog Treat 2022; 33: 3039–3046. [Google Scholar]
  21. Bakhtiar R, Noor SM, Paracha MM. Effectiveness of oral methotrexate therapy versus systemic corticosteroid therapy in treatment of generalised lichen planus. J Coll Physicians Surg Pak 2018; 28: 505–508. [Google Scholar]
  22. Carbone M, Carrozzo M, Castellano S, Conrotto D, Broccoletti R, Gandolfo S. Systemic corticosteroid therapy of oral vesiculoerosive diseases (OVED). An open trial. Minerva Stomatol 1998; 47: 479–87. [Google Scholar]
  23. Chauhan P, De D, Handa S, Narang T, Saikia UN. A prospective observational study to compare efficacy of topical triamcinolone acetonide 0.1 per cent oral paste, oral methotrexate and a combination of topical triamcinolone acetonide 0.1 per cent and oral methotrexate in moderate to severe oral lichen planus. Dermatol Ther 2018; 31: 12563. [Google Scholar]
  24. Pedraça ES, da Silva EL, de Lima TB, Rados PV, Visioli F. Systemic non-steroidal immunomodulators for oral lichen planus treatment: a scoping review. Clin Oral Investig 2023; 27: 7091–7114. [Google Scholar]
  25. Lajevardi V, Ghodsi SZ, Hallaji Z, Shafiei Z, Aghazadeh N, Akbari Z. Treatment of erosive oral lichen planus with methotrexate. J Dtsch Dermatol Ges 2016; 14: 286–293. [Google Scholar]
  26. Myers EL, Hollis AN, Culton DA. Effectiveness and tolerability of systemic therapies in oral lichen planus: a retrospective cohort study. JAAD Int 2024; 15: 136–138. [Google Scholar]
  27. Wee JS, Shirlaw PJ, Challacombe SJ, Setterfield JF. Efficacy of mycophenolate mofetil in severe mucocutaneous lichen planus: a retrospective review of 10 patients. Br J Dermatol 2012; 167: 36–43. [Google Scholar]
  28. Dalmau J, Puig L, Roé E, Peramiquel L, Campos M, Alomar A. Successful treatment of oral erosive lichen planus with mycophenolate mofetil. J Eur Acad Dermatol Venereol 2007; 21: 259–260. [Google Scholar]
  29. Verma KK, Mittal R, Manchanda Y. Azathioprine for the treatment of severe erosive oral and generalized lichen planus. Acta Derm Venereol 2001; 81: 378–379. [CrossRef] [PubMed] [Google Scholar]
  30. Radfar L, Wild RC, Suresh L. A comparative treatment study of topical tacrolimus and clobetasol in oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008; 105: 187–193. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.